1. Home
  2. ADMA vs CRVL Comparison

ADMA vs CRVL Comparison

Compare ADMA & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CRVL
  • Stock Information
  • Founded
  • ADMA 2004
  • CRVL 1987
  • Country
  • ADMA United States
  • CRVL United States
  • Employees
  • ADMA N/A
  • CRVL N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CRVL Specialty Insurers
  • Sector
  • ADMA Health Care
  • CRVL Finance
  • Exchange
  • ADMA Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • ADMA 3.7B
  • CRVL 4.4B
  • IPO Year
  • ADMA N/A
  • CRVL 1991
  • Fundamental
  • Price
  • ADMA $15.05
  • CRVL $76.23
  • Analyst Decision
  • ADMA Strong Buy
  • CRVL
  • Analyst Count
  • ADMA 3
  • CRVL 0
  • Target Price
  • ADMA $27.67
  • CRVL N/A
  • AVG Volume (30 Days)
  • ADMA 3.1M
  • CRVL 157.7K
  • Earning Date
  • ADMA 11-06-2025
  • CRVL 11-04-2025
  • Dividend Yield
  • ADMA N/A
  • CRVL N/A
  • EPS Growth
  • ADMA 469.09
  • CRVL 27.81
  • EPS
  • ADMA 0.85
  • CRVL 1.93
  • Revenue
  • ADMA $474,174,000.00
  • CRVL $918,578,000.00
  • Revenue This Year
  • ADMA $21.17
  • CRVL N/A
  • Revenue Next Year
  • ADMA $26.03
  • CRVL N/A
  • P/E Ratio
  • ADMA $17.41
  • CRVL $38.26
  • Revenue Growth
  • ADMA 43.58
  • CRVL 12.46
  • 52 Week Low
  • ADMA $13.50
  • CRVL $70.47
  • 52 Week High
  • ADMA $25.67
  • CRVL $128.61
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 47.74
  • CRVL 50.08
  • Support Level
  • ADMA $14.35
  • CRVL $70.47
  • Resistance Level
  • ADMA $15.60
  • CRVL $76.86
  • Average True Range (ATR)
  • ADMA 0.52
  • CRVL 1.73
  • MACD
  • ADMA 0.13
  • CRVL 0.85
  • Stochastic Oscillator
  • ADMA 65.17
  • CRVL 93.51

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: